Clinical Trials Directory
We are doing this study to understand how sex hormones (chemicals that tell cells and body parts to do certain things), such as estrogens and androgens, impact skin diseases like hidradenitis suppurativa (HS). To better understand this, we are enrolling both people who have diagnosed skin diseases and healthy volunteers who have no skin issues.
We are doing this study to collect data and samples to store them for future research. We hope the data and samples will lead to improved treatment of patients who are seriously ill or have been injured.
The purpose of this research study is to determine whether data from mobile health technologies (such as smartwatches and smartphones) can be used to assess risk of prediabetes and type 2 diabetes. Using data from smartphones and smartwatches, we may be able to develop a noninvasive procedure for identifying patients who are at risk and should be tested for diabetes. Participants can earn up to $50. For more information about who can be in this study, please contact the study team at diabeteswatch2@duke.edu.
We are testing a new type of electrode and a special computer system that can read signals from the skin. The person in the study will wear these new electrodes on their feet.
In this study, participants will complete two or three in-person visits where they answer surveys and walk for six minutes. After that, they will be placed into one of two groups. One group will start the exercise and nutrition program right away, and the other group will start the program later. The program lasts for twelve weeks. During this time, there will be classes three times each week that last one hour. There will also be a nutrition session every other week. Participants do not need to attend every session, but they are asked to come to at least two thirds of the classes.
We are doing this study to learn more about the connection between the brain and leg muscles in people who have chronic stroke. We want to understand how this connection affects the walking abilities of chronic stroke patients so we can provide better help to stroke patients who need to improve their motor function.
People in the study will have one visit that lasts about 20 minutes. During this visit, the researchers will ask for basic information like age, gender, and race or ethnicity. They will also look at skin color using a special chart called the Monk Skin Tone scale. Next, trained workers will use a small device called the InfraScanner 2500TM to check different parts of the head. These parts include the front, sides, and back. The device is safe, approved by the FDA, and does not use harmful radiation. It uses light to do its job and does not hurt. This study does not give medicine, does not pick people randomly, and does not share test results with the participants.
If you participate, you will be asked to provide a blood draw of about 5.4 mL, or 1/3 tablespoon, of blood. If you are one of the first 20 subjects, you may have the chance to participate in one additional blood draw.